Bausch Health Companies Inc
Veridion Score
Composite trend over time
Why is BHC moving today?
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum of its revenue from the Bausch + Lomb segment.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Warehouse intelligence for BHC.
BHC insider activity
Bausch Health Companies Inc
3 insiders bought in the last 90 days
Net buying: $338.2M across loaded Form 4 rows.
Loaded official disclosures do not show all three sources aligned on this ticker.
| Filing date | Trade date | Insider | Title | Type | Price | Qty | Owned | Value | Receipt |
|---|---|---|---|---|---|---|---|---|---|
| 2026-07-02 | 2026-06-30 | WECHSLER AMY B | Insider | buy | $4.93 | 1,394 | 314,979 | $7K | SEC Form 4 |
| 2026-07-02 | 2026-06-30 | Paulson John | Insider | buy | $4.93 | 12,677 | 430,242 | $62K | SEC Form 4 |
| 2026-07-02 | 2026-06-30 | LEUNG SANDRA | Insider | buy | $4.93 | 6,845 | 97,070 | $34K | SEC Form 4 |
| 2026-05-20 | 2026-05-19 | Lee Frank D. | Insider | sell | $5.43 | 24,456 | 49,339 | $133K | SEC Form 4 |
| 2026-04-02 | 2026-03-31 | WECHSLER AMY B | Insider | buy | $5.40 | 1,273 | 267,714 | $7K | SEC Form 4 |
Showing 5 recent rows. Sovereign unlocks 25 additional rows, full sorting, and the named-filer history.
Upgrade to Sovereign · $25/moBHC contract awards, year to date.
Public federal awards linked to this ticker.
BHC lobbying filings, year to date.
Registered lobbying filings matched to Bausch Health Companies Inc.